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Minocycline is a widely used glial activation inhibitor that could suppress pain-related behaviors in a
number of different pain animal models, yet, its analgesic mechanisms are not fully understood.
Hyperpolarization-activated cation channel-induced Ih current plays an important role in neuronal
excitability and pathological pain.
In this study, we investigated the possible effect of minocycline on Ih of substantia gelatinosa neuron
in superﬁcial spinal dorsal horn by using whole-cell patch-clamp recording.
We found that extracellular minocycline rapidly decreases Ih amplitude in a reversible and
concentration-dependent manner (IC50 ¼ 41 mM). By contrast, intracellular minocycline had no effect.
Minocycline-induced inhibition of Ih was not affected by Naþ channel blocker tetrodotoxin, glutamate-
receptor antagonists (CNQX and D-APV), GABAA receptor antagonist (bicuculine methiodide), or glycine
receptor antagonist (strychnine). Minocycline also caused a negative shift in the activation curve of Ih,
but did not alter the reversal potential. Moreover, minocycline slowed down the inter-spike depolarizing
slope and produced a robust decrease in the rate of action potential ﬁring.
Together, these results illustrate a novel cellular mechanism underlying minocycline's analgesic effect
by inhibiting Ih currents of spinal dorsal horn neurons.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hyperpolarization-activated cation current (Ih) is conducted by
hyperpolarization-activated cyclic nucleotide-gated (HCN) chan-
nels and has been described in multiple neuronal types, such as
thalamic neurons, hippocampal CA1 pyramidal neurons, primary
afferent neurons, and spinal dorsal horn neurons (Doan et al., 2004;
Gao et al., 2012; Ingram and Williams, 1996; McCormick and Pape,
1990; Nolan et al., 2004; Rivera-Arconada et al., 2013). It is a mixed
inward cationic current carried by Naþ and Kþ. Therefore, Ih de-
polarizes the plasma membrane, brings the membrane potential
toward the ﬁring threshold. Diverse functions have been attributed
to Ih, including the determination of resting membrane potentialhe First Afﬁliated Hospital of
þ86 791 88692139; fax: þ86
Ltd. This is an open access article u(RMP), action potential (AP) ﬁring rate, dendritic integration, and
synaptic transmission (Biel et al., 2009; He et al., 2014). The HCN
channel family has four distinct members (HCN1-4) (Biel et al.,
2009). In superﬁcial spinal dorsal horn, complete Freund's
adjuvant-induced inﬂammation increased HCN2 expression (Weng
et al., 2012). Genetic deletion of HCN2 in nociceptors eliminated Ih
and abolished AP ﬁring, which results in non-response to patho-
logical pain stimulation (Emery et al., 2011). In an HCN1/ mouse
model for neuropathic pain, cold allodynia was attenuated
compared to wild-type mice (Momin et al., 2008). In addition, the
selective Ih channel blocker ZD7288 reduced licking/biting
behavior in formalin test, probably due to the reduction of A/C-
ﬁber-mediated evoked excitatory postsynaptic currents (eEPSCs)
and the frequency of miniature EPSCs in substantia gelatinosa (SG)
neurons (Takasu et al., 2010). SG (lamina II of Rexed in spinal dorsal
horn) is a narrow cellular band near the dorsal limit of the gray
matter. SG is thought to be consisted of both excitatory and
inhibitory neurons interconnected in a complicated, but not
completely characterized circuit. However, it has been demon-
strated that a vast majority of neurons are excitatory interneuronsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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from periphery before transmitting to brain and thus is a critical
site in pain modulation (Wall, 1980). These studies indicate that Ih
is a critical contributor and an attractive target for the treatment of
inﬂammatory and neuropathic pain.
Over the past decade or so, an increasing number of studies have
been reported to develop therapy for this type of pain. For instance,
although minocycline is a second-generation of semi-synthetic
tetracycline that has been used as a broad-spectrum antibiotic for
over 30 years, its analgesic property was initially described in 2003
(Raghavendra et al., 2003). In a rat model of L5 spinal nerve tran-
section, intraperitoneal administration of minocycline potently
attenuated mechanical allodynia and hyperalgesia. More recently,
growing interest in minocycline has led to evaluations of its efﬁcacy
in various pain experimental models, such as formalin-evoked in-
ﬂammatory pain (Cho et al., 2006; Hua et al., 2005), spinal nerve
ligation (SNL) or chronic constriction injury (CCI) induced neuro-
pathic pain (Katsura et al., 2006; Owolabi and Saab, 2006; Zanjani
et al., 2006; Zhuang et al., 2005), burn injury pain (Chang and
Waxman, 2010), diabetic neuropathic pain (Liao et al., 2011;
Pabreja et al., 2011; Syngle et al., 2014), visceral pain (Cho et al.,
2012; Liu et al., 2012), and cancer induced pain (Mao-Ying et al.,
2012). In addition, minocycline has been shown to enhance the
analgesic effect when co-administered with morphine or tramadol
(Makuch et al., 2013; Mei et al., 2013; Mika et al., 2009; Zychowska
et al., 2013). The mechanism underlying minocycline-induced
analgesia could be mediated by suppressing microglial activation,
which is independent of its antimicrobial action. Besides inhibition
of glial activation, minocycline may also directly affect neuronal
activity, indicating a non-glial mechanism of action. Also, several
studies have revealed that minocycline exerts anti-nociceptive ef-
fect by reducing neural excitability. For instance, minocycline
inhibited Naþ channel currents in DRG (Kim et al., 2011). Bath
application of minocycline reversibly inhibited nearly 30% of
eEPSCs amplitude in SG neurons, which was compatible to
ZD7288's effect on eEPSCs in SG (Cho et al., 2006; Takasu et al.,
2010).
Regardless of the progress made in understanding the analgesic
action of minocycline as mentioned above, the mechanism under-
lying this neural analgesic effect still remains elusive. Given the
crucial role of Ih in pain and widespread expression of HCN chan-
nels in spinal dorsal horn (Antal et al., 2004; Hughes et al., 2013;
Papp et al., 2006; Tu et al., 2004; Weng et al., 2012), we hypothe-
sized that minocycline might exert its anti-nociceptive effect by
suppressing excitability of SG neuron through action on HCN
channels. Therefore, in this study, we tested this hypothesis by
examining the action of minocycline on Ih using whole-cell patch-
clamp recording in SG neurons of rat spinal cord. As a result, we
found that minocycline decreases Ih amplitude, alters activa-
tionedeactivation properties of Ih, and further decreases frequency
of AP. This ﬁnding might at least interpret how minocycline can
exert its neuronal analgesic action by suppressing excitability of SG.
2. Materials and methods
Male Sprague Dawley rats (3e5 weeks old) were used in this study. All exper-
imental protocols were approved by the Institutional Animal Care and Use Com-
mittee of Nanchang University. All efforts were made to minimize animal suffering
and reduce the number of animals used.
2.1. Spinal cord slice preparation
Spinal cord slices were prepared as described previously (Lu et al., 2013; Yasaka
et al., 2010; Zheng et al., 2010). In brief, rats were anesthetized with urethane (1.5 g/
kg, i.p.), and then perfused transcardially for 2 minwith ice-cold oxygenated (95% O2
and 5% CO2) sucrose-substituted artiﬁcial cerebrospinal ﬂuid (sucrose-ACSF:
240 mM sucrose; 2.5 mM KCl; 0.5 mM CaCl2; 3.5 mM MgCl2; 1.25 mM NaH2PO4;
25 mM NaHCO3; 0.4 mM ascorbate acid; and 2 mM pyruvate). The lumbosacralspinal cord was quickly removed and placed in ice-cold oxygenated sucrose-ACSF.
After extraction and still under anesthesia, animals were sacriﬁced by decapita-
tion. Parasagittal slices (300-mm thick) were prepared using a vibrating microslicer
(VT1000S; Leica). The slices were incubated at 32 C for at least 30 min in regular
ACSF (117 mM NaCl; 3.6 mM KCl; 2.5 mM CaCl2; 1.2 mM MgCl2; 1.2 mM NaH2PO4;
25 mM NaHCO3; 11 mM D-glucose; 0.4 mM ascorbic acid; and 2 mM pyruvate)
equilibrated with 95% O2 and 5% CO2.
2.2. Electrophysiological recording
The electrophysiological recording procedures and labeling of neurons were
conducted basically as described previously (Rivera-Arconada et al., 2013; Yasaka
et al., 2010). Speciﬁcally, an individual slice was transferred to a recording cham-
ber and placed on the stage of an upright microscope (BX51WI; Olympus). Tight seal,
whole-cell patch-clamp recordings were performed at room temperature
(22e24 C) and perfused at a rate of 2e4 ml/min with ACSF. SG neurons in lumbar
segments L4-L5 were identiﬁed by their locations and visualized under guidance of
an infrared and differential interference contrast (IR-DIC) camera. Recording pi-
pettes were fabricated from borosilicate glass capillaries (1.5 mm OD, 1.12 mm ID;
World Precision Instruments) on amicropipette puller (P-97; Sutter Instrument) and
had a resistance of 4e6 MU when ﬁlled with a solution containing the following:
130 mM K-gluconate; 5 mM KCl; 4 mMMg-ATP; 10 mM phosphocreatinine; 0.3 mM
Li-GTP; 10 mM Hepes (pH 7.3 adjusted with KOH, 300 mOsm). No correction for the
liquid junction potential was made. Signals were ampliﬁed using an EPC-10
ampliﬁer with Patchmaster software (HEKA) and stored for off-line analysis. In
this study, the series resistances were usually 30e50 MU. Neurons that showed a
RMP more positive than 50 mV and their series resistance changed by more than
20% were excluded from analysis.
2.3. Experimental protocol
Somatic Ih current was activated as described previously (Gao et al., 2012;Weng
et al., 2012). In current-clamp mode, a series of negative current injections (30
to300 pAwith a step of 30 pA, 1 s duration) was applied to evoke a set of voltage
sags [in our study, some of the neurons can't tolerate excessive hyperpolarizing
current, so we used a smaller current intensity than used in DRG (Gao et al., 2012)].
In voltage-clamp mode, Ih was evoked by a series of hyperpolarizing step voltage
pulses from a holding potential of 50 mV to130 mV for 1 s in 10-mV increments.
Ih amplitude was measured as the difference between the initial (instantaneous)
inward current (Iini) and the steady state current (Iss) at130 mV unless mentioned
otherwise. The Iini was measured 12e15 ms after the start of the voltage command
to avoid contamination by capacitative artifacts.
For voltage dependent activation studies, neuron was held at 50 mV, and Ih
currents were allowed to be partially activated by hyperpolarizing test commands
within the range from 60 to 130 mV in 10-mV increments (duration: 1 s). The
neuronwas then subjected to a voltage jump to130 mV to obtain full activation of
Ih currents. Instantaneous tail currents were normalized to the maximum value
obtained with the 130 mV prepulse and plotted against the corresponding pre-
pulse voltages to yield activation curves. The curve was ﬁtted with a Boltzmann
sigmoid equation: I/Imax ¼ 1/(1 þ exp[(V0.5  V)/k]), in which Imax represents the
maximal current amplitude, V0.5 is the voltage, at which the current is one half of its
maximal level, V is the membrane voltage, and k is the constant slope factor. Ih
density was calculated by dividing Ih amplitude by cell capacitance.
The currentevoltage (IeV) relationship of Ih was obtained from tail currents
measuredwith the following voltage protocol. Themembrane potential was stepped
to 130 mV for 1 s from a holding potential of 50 mV to fully activate Ih followed
by a depolarization to test potentials of 120 to 50 mV in 10-mV increments. The
time point for measurement of the peak tail current is usually just after the
capacitive transient at each test voltage. The recorded tail current amplitudes were
plotted against each test potential to construct the IeV lines. Reversal potential
(Vrev) is the intersection of the IeV line with the X-axis.
APs were evoked with a series of depolarizing current (25e175 pA in 25 pA
steps) injections of 1-s duration in current-clamp mode. AP frequency was deter-
mined as the spike number in 1 s.
2.4. Application of drugs
All drugs were bath applied by gravity perfusion via a three-way stopcock
without any change in the perfusion rate. The time necessary for the solution to ﬂow
from the stopcock to the surface of the spinal cord slice was approximately 10 s. The
drugs used here include minocycline, 1 mM CsCl (a nonspeciﬁc Ih blocker), 10 mM
ZD7288, 0.1 mM NiCl2 (a voltage-gated Ca2þ channel blocker), 1 mM 4-AP (a low-
voltage activating potassium channel blocker), 10 mM TEA (a high-voltage acti-
vating potassium channel blocker), 1 mM BaCl2 (an inward-rectiﬁer Kþ channel
blocker), 0.5 mM TTX (a sodium channel blocker), 10 mM CNQX (an AMPA/kainite
receptor antagonist), 50 mMD-APV (an NMDA receptor antagonist),10 mMbicuculine
methiodide (a GABAA receptor antagonist), 1 mM strychnine (a glycine receptor
antagonist), and 50 mM forskolin (a potent nonspeciﬁc adenylyl cyclase activator).
CsCl, BaCl2, NiCl2, TEA, and 4-AP were freshly dissolved at the ﬁnal concentration
directly in ACSF before use. Stock of CNQX and froskolin were ﬁrst dissolved in
Fig. 1. Recording the Ih currents from substantia gelatinosa (SG) neurons in lamina II of spinal dorsal horn. A: Representation of the position of SG in a parasagittal spinal cord slice
(a), IR-DIC image (b), and image of the same cell revealed by intracellular dialysis with neurobiotin 488 10 min after whole-cell conﬁguration (c). B: Representative voltage sag of
membrane potential evoked in a SG neuron by a series of hyperpolarizing current injections (top panel) under current-clamp mode. C: In voltage-clamp mode, Ih was evoked, in the
same neuron shown in (B), by a series of hyperpolarizing voltage steps (top panel). Open circles in the lowest Ih trace indicates the initial (Iini) and steady state (Iss) of Ih
at 130 mV. D: Sample traces under control condition and following application of either 1 mM BaCl2, 0.1 mM NiCl2, 1 mM CsCl, or 10 mM ZD7288 from the same neuron. E:
Superimposed traces (at 130 mV) of control, BaCl2, NiCl2, CsCl, and ZD7288 shown in (D). F: Representative enhanced Ih current trace by forskolin. G: Graphic presentation of the
effects of the blockers on Ih inhibition and forskolin on Ih enhancement. Values in each bar represent the number of experiments (*: P < 0.05; n.s.: not signiﬁcant difference).
Fig. 2. Minocycline reduces Ih in SG neurons. A: Representative current responses evoked by hyperpolarizing voltage steps in the absence, presence, and washout of minocycline
(100 mM). B: Superimposed traces of Ih (at 130 mV) illustrated in (A). C: Exemplary time course of the effect of minocycline on Ih amplitude (the same neuron in A) which showed
that the inhibition is rapid and reversible. Minocycline were applied during periods indicated by black bars. D: Summarization of the effect of minocycline on Ih currents. E: Effect of
Ih in the absence and presence of minocycline in ACSF solution containing mixed blockers including TTX, CNQX, D-APV, bicuculine methiodide, and strychnine. F: Superimposed
traces (at 130 mV) of the recording in (E). G: Graphic presentation of the results showing that minocycline induces Ih inhibition in the presence (blank) and absence (stripe) of
mixed blockers.
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at 1000 times the concentrations to be used and stored at 20 C. These drugs were
then diluted to the ﬁnal concentration in ASCF solution immediately before use. The
concentration of DMSO in ASCF solution containing the drugs was <0.1%. TTX,
ZD7288, CNQX, D-APV, and forskolinwere purchased from Tocris Bioscience (Bristol,
UK). All the other drugs were obtained from SigmaeAldrich (St. Louis, MO). The
determination of doses for each drug was based on those found to be effective in
previous studies (Cho et al., 2006; Rivera-Arconada et al., 2013; Yao et al., 2003).
2.5. Statistical analysis
All statistical analyses and curve ﬁttings were performed using GraphPad Prism
5.0 (GraphPad Software, USA). Data are expressed as mean ± SEM unless otherwise
mentioned, and n refers to the number of neurons studied. Statistical signiﬁcance of
data from different drug conditions was assessed with Student's t-test, one- or two-
way ANOVA as appropriate. Statistical signiﬁcance is indicated as follows: *P < 0.05;
**P < 0.01; and ***P < 0.001.
3. Results
3.1. Recording Ih currents in SG neurons
Whole-cell recordings were obtained from a total of 169 SG
neurons with Ih currents. These neurons were identiﬁed using IR-
DIC video microscopy based on their location, which is lateral to
the dorsal column and distinguished as a relatively translucent
band (Fig. 1Aa). A typical example of an SG neuron is shown along
with their morphology (Fig. 1Ab, c), indicating that the cell body is
clearly located in lamina II with numerous dendritic trees. As
described previously (Liu et al., 2013), all SG neurons examined had
RMP more negative than 50 mV in this study when measured inFig. 3. Intracellular minocycline does not inhibit Ih in SG. A: Ih recordings obtained in the p
and in the presence of extracellular 100 mM minocycline (red). B: Superimposed traces of Ih
and the following extracellular minocycline on Ih amplitude (the same neuron in A). D: G
intracellular and extracellular addition of minocycline. (For interpretation of the referencesthe current-clamp mode. When tested with a series of hyper-
polarizing current (Fig. 1B top) or voltage pulses (Fig. 1C top), some
of these neurons exhibited a depolarizing “sag” (Fig. 1B bottom) or
inward current (Fig. 1C bottom), due to activation of HCN channel.
Ih was comprised of Iini and Iss (Fig. 1C bottom) and displayed
reproducible time and voltage-dependent activation patterns
similar to those previously stated (Gao et al., 2012; Liu et al., 2003).
Consistent with the previously reported Ih in SG, Ihwas observed in
nearly 50% (169/340) of recorded cells, which were chosen for
further testing (Grudt and Perl, 2002; Melnick, 2008; Tadros et al.,
2012; Yasaka et al., 2010).
To ensure that the current recorded in this study is Ih, we
examined the effect of CsCl and ZD7288 on Ih, both of which have
been shown to block Ih current effectively. Similar to a previous
study (Doan et al., 2004), we found that Ih currents are blocked by
CsCl and ZD7288 (Fig. 1D, E). To further determine whether Ih
currents recorded in SG neurons are contaminated by other cur-
rents, such as voltage-gated potassium and calcium currents, we
bath applied BaCl2, 4-AP, TEA, or NiCl2 to the slices, respectively
(Dibattista et al., 2008; Du et al., 2013; Kwak, 2012; Rivera-
Arconada et al., 2013). We found that Ih currents are not signiﬁ-
cantly changed by BaCl2, NiCl2, 4-AP, and TEA (Fig. 1DeG). These
results conﬁrmed that the current recorded in SG neurons is HCN
channel-mediated Ih current, with little or no contamination with
other currents.
The four subtypes of HCN channels exhibit distinct cAMP-
sensitivity. HCN2 and HCN4 can be modulated positively,resence of 100 mM minocycline in the patch pipette in normal extracellular ACSF (blue)
(at 130 mV) illustrated in (A). C: Exemplary time course of the effect of intracellular
raphic presentation showing the percentage change of the amplitude of Ih during the
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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To assess whether HCN channels in SG neurons contain the cAMP-
sensitive subunits, 50 mM forskolin was bath applied for 10 min to
spinal slices. In only 4 of 21 neurons examined, forskolin caused an
increase in Ih amplitude (156 ± 25%, P < 0.05; Fig. 1F). Other 17
neurons were not affected by forskolin. Thus, these results indicate
that most of the Ih currents recorded in this study are induced by
cAMP-insensitive HCN channels, probably HCN1 or HCN3. The
distinct composition of HCN channel in SG neurons requires further
study. The effects of different channel blockers and forskolin on Ih
current amplitude are summarized in Fig. 1G.3.2. Minocycline decreases the amplitude of Ih in SG neurons
Although recent studies showed the modulation of neuronal
excitability by minocycline, little is known about if this medicine
might modulate Ih. In the present study, minocycline was given for
3 min and the maximum effects weremeasured 3e5min after bath
application of minocycline. Control Ih amplitude was measured
1 min before the application of minocycline. There was some
variability in Ih amplitude among neurons, ranging from 24
to 590 pA (171 ± 12 pA; n ¼ 169). After superfusion of 100 mM
minocycline, the amplitude of Ih signiﬁcantly decreased to 62 ± 5%
(n ¼ 15; P < 0.01) of the control (145 ± 27 pA; Fig. 2A, B). In 15
cells, a recovery of current amplitude to 84 ± 7% was observed after
washing out minocycline (P > 0.05; Fig. 2A, B). As shown in the time
course experiment (Fig. 2C), Ih amplitude decreased right after
minocycline application and reached a maximum level withinFig. 4. Minocycline inhibits Ih in a concentration-dependent way. A: Exemplar Ih traces
amplitude in a concentration-dependent manner. B: Superimposed Ih traces from (A) at 13
curve for the effects of minocycline on Ih. Each point represents the minocycline-induced Ih
their respective controls. The curve was ﬁtted by Hill equation: y ¼ Imax/ (1 þ IC50/k), wheapproximately 3e5 min afterward. The decrease usually subsided
within 20e30 min after washout of minocycline. These results
indicate that minocycline rapidly inhibits Ih in SG neurons, which is
reversible.
Two previous studies revealed the presence of HCN channels in
certain axons and presynaptic terminals of nociceptive primary
afferents by immunohistochemical staining (Antal et al., 2004;
Papp et al., 2010). To examine whether presynaptic HCN channels
and synaptic transmission are involved in minocycline-induced
reduction of Ih, we co-applied a mixed blocker solution contain-
ing TTX, CNQX, D-APV, bicuculine methiodide, and strychnine. As
shown in Fig. 2E and F, minocycline caused a signiﬁcant decrease in
magnitude of Ih when slices were pre-superfused with the mixed
blockers (60 ± 7% of control: 181 ± 56 pA; n ¼ 8; P < 0.01), which
was comparable to the Ih inhibition by bath application of mino-
cycline (Fig. 2G). Therefore the inhibitory effect of minocycline on
Ih is unlikely to be associated with axonal and presynaptic HCN
channels as summarized in Fig. 2G.
To further elucidate the site of minocycline's action, we tested
the efﬁcacy of intracellularly versus extracellularly applied mino-
cycline. Inclusion of 100 mMminocycline in the pipette solution did
not affect Ih amplitude (94 ± 4% of control: 206 ± 69 pA; n ¼ 4;
P > 0.05) after establishing whole-cell conﬁguration within 10 min
(Fig. 3A, B). However, when we continued to apply extracellular
minocycline (100 mM) to the same neuron, Ih amplitude was
decreased rapidly (67± 9%, n¼ 4; P < 0.05) (Fig 3C). These results as
summarized in Fig. 3D indicate an extracellular location of the
minocycline binding site.recorded from the same neurons demonstrating that minocycline reduces Ih current
0 mV before and after exposure to minocycline at each concentration. C: Dose-response
block in the presence of increasing concentrations of minocycline and normalized to
re x is minocycline concentration in mM; IC50 was 41 mM and Hill coefﬁcient was 2.2.
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concentration-dependent
To determine IC50 for the inhibitory effect of minocycline on Ih,
we performed a dose-dependent experiment by using a standard
voltage protocol (see Fig. 1D) in the absence or presence of
increasing amounts of minocycline. Indeed, as shown in Fig. 4AeC,
this medicine inhibited Ih in a dose-dependent fashion. Hill plot
analysis of the data revealed that the IC50 value of this inhibition is
41 mM with a Hill coefﬁcient of 2.2.3.4. Negative shift of Ih activation curve by minocycline
To examine whether minocycline modulates HCN channel
activation in SG neurons, we employed the protocol for activation
curve plotting (Fig. 5A). The tail currents were shown in detail in
Fig. 5B. The activation curves were ﬁtted by using the Boltzmann
equation (see the Methods) and generated before and after super-
fusion of 100 mM minocycline (each point represents the
mean ± SEM of 10 cells; Fig. 5D). V0.5 were 86.9 ± 1.4 mV in
control conditions and 95.5 ± 1.7 mV in the presence of mino-
cycline, which revealed a negative shift of 8.6 mV (n ¼ 10;
P < 0.05, Fig. 5D). However, the slope factors for controlFig. 5. Negative shift of the Ih activation curve by minocycline. A: Example (top) and
Enlargement of the tail currents in the rectangle of (A). Tail currents (marked by arrow)
max  Ttail)/Ttail, max] and plotted against the corresponding prepulse voltages to build the vo
reduced the amplitude of the tail currents evoked with the same voltage protocol (same n
was 86.9 mV in control and 95.5 mV in minocycline, a negative shift of 8.6 mV (n ¼ 10)
Error bars indicate SEM.(12.0 ± 1.3 mV) and minocycline (14.3 ± 1 mV) were not signiﬁ-
cantly different (P > 0.05).
When normalized to cell capacitance, superfusion of minocy-
cline had a signiﬁcant decrease in Ih current density by 40e45%
compared with control neurons over the voltage range from 100
to 130 mV (n ¼ 10; Fig 5E). Although at 70 mV, the current
density values obtained in the absence and presence of minocycline
were similar (0.4 ± 0.2 and 0.2 ± 0.1 pA/pF, respectively),
at 130 mV, these values were signiﬁcantly different (7.8 ± 1.6 and
4.7 ± 1.0 pA/pF, respectively; P < 0.05) with a 40% decrease in the
latter group (Fig. 5E).
3.5. Effects of minocycline on reversal potential of Ih current
To further examine the effects ofminocycline on the Vrev of Ih in
SG neurons, we used the voltage protocol described in the pre-
ceding text (Fig. 6A). Tail currents were measured at the start of the
test potentials and time point for measuring the peak tail current is
shown in Fig. 6B. Minocycline reduced tail current amplitude
compared to the control group (Fig. 6C). IeV curvewas generated in
8 Ih-expressing neurons (Fig. 6D). The intercept of the resulting
curve with the X-axis and the slope represented Vrev and
conductance, respectively. The Vrev values of 42.0 ± 0.5 mV ob-
tained after the application of 100 mM minocycline were notprotocol (lower) for activation curve plotting from hyperpolarizing tail currents. B:
were normalized to the maximum value obtained with the 130 mV prepulse [(Ttail,
ltage activation curve shown in (D). C: Bath application of minocycline (100 mM) greatly
euron as in A). D: Minocycline (100 mM) negatively shifted the activation curve. V0.5
. E: Ih current density (current amplitude/cell capacitance) versus membrane potential.
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(n ¼ 8; P > 0.05), suggesting that minocycline did not change the
ion selectivity of HCN channels. This Vrev is consistent with a
mixed cation channel permeable for sodium and potassium and is
in the range of Vrev described for HCN channels (Van Hook and
Berson, 2010).3.6. Minocycline decreases AP ﬁring rates in SG neurons
Given the critical role of Ih in determining intrinsic excitability,
we further determined whether minocycline would affect the basic
ionic mechanisms of spike generation in SG neurons. An example of
the responses of one SG neuron to depolarizing current injections
in the absence and presence of minocycline is shown in Fig. 7A. This
result revealed the reduction of ﬁring frequency. As illustrated in
Fig. 7B, minocycline slowed down the slope of the depolarization
ramp leading to AP threshold and prolonged interspike intervals
resulting in the reduction of spike frequency. Bath application of
minocycline decreased AP ﬁring rate from 32 ± 5 to 16 ± 4 Hz
(n¼ 8; P < 0.05) by a 175 pA current injection (Fig. 7A, D). However,
superimposition of AP spikes recorded before and after application
of minocycline revealed minimal effects on the amplitude, dura-
tion, and shape of the APs (Fig 7C). The decreases in spike numbers
of 8 neurons as summarized in Fig 7D strongly indicate that min-
ocycline markedly alters the intrinsic properties of SG neurons.Fig. 6. Effect of minocycline on the reversal potential of Ih. A: Example recording (top) and
enlargement of the rectangle shown in (B), the vertical arrow indicates the point at which Ide
the test potentials (arrows). C: Bath application of minocycline (100 mM) greatly reduced the
in A). D: IeV plots of Ideact against test potential voltages before and after superfusion of mino
(n ¼ 8). Vrev is the intersection of the IeV line with the X-axis. Vrev were 42.0 ± 0.5 and4. Discussion
The results as presented here demonstrate that minocycline
acutely and signiﬁcantly decreases the Ih amplitude of SG neurons,
which is irrelevant to its antibiotic and inhibitory effect on micro-
glia activation. This reduction was mediated by postsynaptic HCN
channels and independent of the cAMP-induced intracellular
signaling pathway.We also found that minocycline shifts Ih current
activation curve to a more negative level, but do not alter Vrev. In
addition, minocycline strongly decreased ﬁring rates of APs by
slowing down the inter-spike depolarizing slope.
It is generally accepted that both central and peripheral
administration of minocycline exerts anti-inﬂammatory and neu-
roprotective effects. Moreover, a number of studies indicate that
minocycline could be used as an antinociceptive agent in pain
management, although the underlying mechanisms remain
obscure. The effect of minocycline might be related to multiple
mechanisms, including decreased microglial activation (Martinez
et al., 2013; Pevida et al., 2013) and subsequent pro-inﬂammatory
cytokine generation (Mao-Ying et al., 2012; Mei et al., 2013),
increased antinociceptive factors (IL-1a, IL-2, IL-10, sTNFRII)
(Zychowska et al., 2013), decreased glutamine release (Huang et al.,
2014), and inhibited NMDAR1 expression (Pu et al., 2013). Based on
the time course of minocycline's effect in our study, the acute
reduction of minocycline on Ih (within several minutes) might not
be due to its inhibitory effect on microglial activation (usuallyprotocol (lower) of the deactivated Ih current (Ideact) for IeV curve plotting. Within an
act was measured to generate the IeV plot. B: Tail currents were measured at the start of
amplitude of the tail currents evoked with the same voltage protocol (same neuron as
cycline. The solid lines are the linear regressions ﬁtted to the data points for each group
40.7 ± 0.5 mV for control and minocycline, respectively.
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attention has been paid to minocycline's effect on the modulation
of neural excitability. For instance, minocycline blocked voltage-
dependent Naþ- and Ca2þ-channels in hippocampal neurons
(Gonzalez et al., 2007), inhibited Naþ currents in DRG neurons (Kim
et al., 2011), and decreased eEPSCs in SG neurons (Cho et al., 2006).
We further showed here for the ﬁrst time that minocycline directly
inhibits somatic HCN channels and hence decreases the excitability
of SG neuron in the spinal dorsal horn. IC50 values for the reduction
of minocycline on Ih was 41 mM, which is comparable to that
(64 mM for frequency and 42 mM for amplitude, respectively) of
sEPSCs in culture hippocampal neurons (Gonzalez et al., 2007) and
about 100 times larger than that (410 nM) in blocking DRG Naþ
currents (Kim et al., 2011). The differences may be due to the cell-
type-speciﬁc or subtype-speciﬁc HCN channel isoforms. In our
study as presented here, maximum blocking effect of minocycline
on Ih was nearly 40%, probably owing to the saturation of binding
site to HCN channels. The similar blocking effect on Ih currents has
been reported for nicotine on oriens-lacunosummoleculare (O-LM)
interneurons (maximum 39%) (Griguoli et al., 2010) and serotonin
on ventral tegmental area neurons (maximum 40%) (Liu et al.,
2003).
HCN channels are expressed in spinal dorsal horn (Antal et al.,
2004; Hughes et al., 2013; Papp et al., 2006; Tu et al., 2004;
Weng et al., 2012), and Ih has been recorded in subset of SG neu-
rons (Grudt and Perl, 2002; Melnick, 2008; Tadros et al., 2012;
Yasaka et al., 2010). The blockade of Ih by CsCl and ZD7288
shown in the present study is in agreement with previous publi-
cations (Doan et al., 2004; Southan et al., 2000; Van Hook andFig. 7. Minocycline decreases the AP frequency and slows down the depolarizing voltage slo
in steps of 25 pA of 1-s duration from the same neuron before and after application of mino
step in control (blue) or in the presence of minocycline (red) shown in (A) is represented on
was prolonged after the application of minocycline (red arrowhead) compared with control
potentials from the traces in (B) are superimposed at a different timescale to shown no mod
of AP in response to increasing injected current strength in control and in 100 mMminocyclin
reader is referred to the web version of this article.)Berson, 2010; van Welie et al., 2004). Besides postsynaptic HCN
channels, axonal and presynaptic HCN channels have also been
reported to be functionally related to synaptic transmission
(Aponte et al., 2006; Chevaleyre and Castillo, 2002; Lupica et al.,
2001; Peng et al., 2010; Southan et al., 2000). Minocycline-
induced inhibition of Ih was not inﬂuenced by bath application of
TTX, CNQX, APV, bicuculine methiodide, and strychinine, which
strongly suggests the direct action of this medicine on postsynaptic
HCN channels.
Four different subunits of HCN channels have been cloned,
which may assemble to form homotetramers or heterotetramers
with different biophysical properties (Biel et al., 2009; He et al.,
2014). Variance of Ih amplitude reﬂects different expression types
of HCN channels in SG neurons. Among them, HCN2 and HCN4, but
not HCN1 and HCN3 subunits have been shown to confer high
sensitivity to cAMP. Additional experiments are needed to deter-
mine the composition of native HCN channels in SG cells. Because
cAMP activator forskolin potentiated Ih in only 19% of the neurons
examined, this suggests that HCN1 or HCN3, but not HCN2 and
HCN4 may be the target of minocycline. In contrast to extracellular
application of minocycline, intracellular included minocycline did
not alter Ih, indicating an extracellular binding site of minocycline
on HCN channels.
Our ﬁndings that the inhibitory effect of minocycline on Ih is
consistent with the signiﬁcantly reduced V0.5 and negatively shift of
activation curve. The effect of minocycline on SG neurons closely
resembles the effect of capsaicin on DRG neurons, which showed a
similar negative shift in the voltage dependence of Ih activation
(Kwak, 2012). The mean activation V0.5 of Ih was 86.9 mV in SGpes. A: Responses to a series of depolarizing current steps from 25 to 175 pA increasing
cycline (100 mM). B: Two superimposed traces of voltage responses to a 175 pA current
an expanded timescale. The depolarization ramp leading to action potential threshold
solution (blue arrowhead), which led to a lower frequency of discharges. C: Two action
iﬁcation of action potential waveforms. D: Graphic presentation showing the frequency
e groups (n ¼ 8). (For interpretation of the references to color in this ﬁgure legend, the
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(Griguoli et al., 2010), stellate cells of the mammalian ventral
cochlear nucleus (86.8 mV) (Rodrigues and Oertel, 2006), and
dorsal horn ganglion neurons (86.3 mV) (Momin et al., 2008).
However, Vrev of Ih was not signiﬁcantly altered by minocycline
(42.0 mV vs.40.7 mV). The lack of a change in Vrev indicates the
ion selectivity of HCN channels is not affected by minocycline. Vrev
values in SG neurons were comparable to ganglion-cell photore-
ceptors (43 mV) (Van Hook and Berson, 2010) and ventral
tegmental area dopamine neurons (39 mV) (Pape and
McCormick, 1989).
Because Ih contributes to pacemaker activity in CNS neurons, it
might also modulate APs of SG neurons. After the application of
minocycline, APs rates were decreased, suggesting that minocy-
cline could reduce the intrinsic excitability of SG neurons possibly
through inhibiting Ih currents. One likely explanation is that min-
ocycline may reduce an inward current already active at rest, which
exerts a tonic depolarizing action on SG cells. This is consistent with
the results showing that ZD7288 decreases APs frequency in
vomeronasal sensory neurons (Dibattista et al., 2008) or ganglion-
cell photoreceptors (Van Hook and Berson, 2010). Speciﬁcally,
minocycline slowed down the slope of the depolarization ramp
leading to AP threshold in our study. Although sodium- and
calcium-gated channels inhibited by minocycline in hippocampal
or DRG neurons (Gonzalez et al., 2007; Kim et al., 2011), they less
likely contributed to SG neurons, because the shape of APs was not
affected by minocycline, indicating a selective action of minocy-
cline on the pacemaker current Ih. Our data is also in agreement
with a previous study showing that the application of 100 mM
minocycline reduces the evoked APs in cultured hippocampal
neurons (Gonzalez et al., 2007).
5. Conclusions
Taken together, our studies as presented here demonstrate that
the actions of minocycline on HCN channels, including the reduc-
tion of Ih amplitude and negative modiﬁcation of the voltage
dependence of activation, are sufﬁcient to suppress the excitability
of SG neurons. As SG is an important element of integration
network in pain transmission, our ﬁndings suggest this medicine as
a potential treatment therapy for HCN channel activation-mediated
chronic pain.
Acknowledgments
This work was supported by grants from the National Natural
Science Foundation of China (No. 81260175). We thank Eiichi
Kumamoto, Hua Lu, and Yao Wang for helpful discussion, com-
ments, and/or editing.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.neuropharm.2015.03.001.
References
Antal, M., Papp, I., Bahaerguli, N., Veress, G., Vereb, G., 2004. Expression of
hyperpolarization-activated and cyclic nucleotide-gated cation channel subunit
2 in axon terminals of peptidergic nociceptive primary sensory neurons in the
superﬁcial spinal dorsal horn of rats. Eur. J. Neurosci. 19, 1336e1342.
Aponte, Y., Lien, C.C., Reisinger, E., Jonas, P., 2006. Hyperpolarization-activated
cation channels in fast-spiking interneurons of rat hippocampus. J. Physiol. 574,
229e243.
Biel, M., Wahl-Schott, C., Michalakis, S., Zong, X., 2009. Hyperpolarization-activated
cation channels: from genes to function. Physiol. Rev. 89, 847e885.Chang, Y.W., Waxman, S.G., 2010. Minocycline attenuates mechanical allodynia and
central sensitization following peripheral second-degree burn injury. J. Pain 11,
1146e1154.
Chevaleyre, V., Castillo, P.E., 2002. Assessing the role of Ih channels in synaptic
transmission and mossy ﬁber LTP. Proc. Natl. Acad. Sci. U. S. A. 99, 9538e9543.
Cho, I.H., Chung, Y.M., Park, C.K., Park, S.H., Lee, H., Kim, D., Piao, Z.G., Choi, S.Y.,
Lee, S.J., Park, K., Kim, J.S., Jung, S.J., Oh, S.B., 2006. Systemic administration of
minocycline inhibits formalin-induced inﬂammatory pain in rat. Brain Res.
1072, 208e214.
Cho, I.H., Lee, M.J., Jang, M., Gwak, N.G., Lee, K.Y., Jung, H.S., 2012. Minocycline
markedly reduces acute visceral nociception via inhibiting neuronal ERK
phosphorylation. Mol. Pain 8, 13.
Dibattista, M., Mazzatenta, A., Grassi, F., Tirindelli, R., Menini, A., 2008. Hyperpo-
larization-activated cyclic nucleotide-gated channels in mouse vomeronasal
sensory neurons. J. Neurophysiol. 100, 576e586.
Doan, T.N., Stephans, K., Ramirez, A.N., Glazebrook, P.A., Andresen, M.C., Kunze, D.L.,
2004. Differential distribution and function of hyperpolarization-activated
channels in sensory neurons and mechanosensitive ﬁbers. J. Neurosci. 24,
3335e3343.
Du, L., Wang, S.J., Cui, J., He, W.J., Ruan, H.Z., 2013. The role of HCN channels within
the periaqueductal gray in neuropathic pain. Brain Res. 1500, 36e44.
Emery, E.C., Young, G.T., Berrocoso, E.M., Chen, L., McNaughton, P.A., 2011. HCN2 ion
channels play a central role in inﬂammatory and neuropathic pain. Science 333,
1462e1466.
Gao, L.L., McMullan, S., Djouhri, L., Acosta, C., Harper, A.A., Lawson, S.N., 2012.
Expression and properties of hyperpolarization-activated current in rat dorsal
root ganglion neurons with known sensory function. J. Physiol. 590,
4691e4705.
Gonzalez, J.C., Egea, J., Del Carmen Godino, M., Fernandez-Gomez, F.J., Sanchez-
Prieto, J., Gandia, L., Garcia, A.G., Jordan, J., Hernandez-Guijo, J.M., 2007. Neu-
roprotectant minocycline depresses glutamatergic neurotransmission and
Ca(2þ) signalling in hippocampal neurons. Eur. J. Neurosci. 26, 2481e2495.
Griguoli, M., Maul, A., Nguyen, C., Giorgetti, A., Carloni, P., Cherubini, E., 2010.
Nicotine blocks the hyperpolarization-activated current Ih and severely impairs
the oscillatory behavior of oriens-lacunosum moleculare interneurons.
J. Neurosci. 30, 10773e10783.
Grudt, T.J., Perl, E.R., 2002. Correlations between neuronal morphology and elec-
trophysiological features in the rodent superﬁcial dorsal horn. J. Physiol. 540,
189e207.
He, C., Chen, F., Li, B., Hu, Z., 2014. Neurophysiology of HCN channels: from cellular
functions to multiple regulations. Prog. Neurobiol. 112, 1e23.
Hua, X.Y., Svensson, C.I., Matsui, T., Fitzsimmons, B., Yaksh, T.L., Webb, M., 2005.
Intrathecal minocycline attenuates peripheral inﬂammation-induced hyper-
algesia by inhibiting p38 MAPK in spinal microglia. Eur. J. Neurosci. 22,
2431e2440.
Huang, C.Y., Chen, Y.L., Li, A.H., Lu, J.C., Wang, H.L., 2014. Minocycline, a microglial
inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of
glutamatergic transmission in substantia gelatinosa neurons. J. Neuroinﬂamm.
11, 7.
Hughes, D.I., Boyle, K.A., Kinnon, C.M., Bilsland, C., Quayle, J.A., Callister, R.J.,
Graham, B.A., 2013. HCN4 subunit expression in fast-spiking interneurons of
the rat spinal cord and hippocampus. Neuroscience 237, 7e18.
Ingram, S.L., Williams, J.T., 1996. Modulation of the hyperpolarization-activated
current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons.
J. Physiol. 492 (Pt 1), 97e106.
Katsura, H., Obata, K., Mizushima, T., Sakurai, J., Kobayashi, K., Yamanaka, H., Dai, Y.,
Fukuoka, T., Sakagami, M., Noguchi, K., 2006. Activation of Src-family kinases in
spinal microglia contributes to mechanical hypersensitivity after nerve injury.
J. Neurosci. 26, 8680e8690.
Kim, T.H., Kim, H.I., Kim, J., Park, M., Song, J.H., 2011. Effects of minocycline on Naþ
currents in rat dorsal root ganglion neurons. Brain Res. 1370, 34e42.
Kwak, J., 2012. Capsaicin blocks the hyperpolarization-activated inward currents via
TRPV1 in the rat dorsal root ganglion neurons. Exp. Neurobiol. 21, 75e82.
Liao, Y.H., Zhang, G.H., Jia, D., Wang, P., Qian, N.S., He, F., Zeng, X.T., He, Y., Yang, Y.L.,
Cao, D.Y., Zhang, Y., Wang, D.S., Tao, K.S., Gao, C.J., Dou, K.F., 2011. Spinal
astrocytic activation contributes to mechanical allodynia in a mouse model of
type 2 diabetes. Brain Res. 1368, 324e335.
Liu, P.Y., Lu, C.L., Wang, C.C., Lee, I.H., Hsieh, J.C., Chen, C.C., Lee, H.F., Lin, H.C.,
Chang, F.Y., Lee, S.D., 2012. Spinal microglia initiate and maintain hyperalgesia
in a rat model of chronic pancreatitis. Gastroenterology 142, 165e173 e2.
Liu, T., Jiang, C.Y., Fujita, T., Luo, S.W., Kumamoto, E., 2013. Enhancement by inter-
leukin-1b of AMPA and NMDA receptor-mediated currents in adult rat spinal
superﬁcial dorsal horn neurons. Mol. Pain 9, 16.
Liu, Z., Bunney, E.B., Appel, S.B., Brodie, M.S., 2003. Serotonin reduces the
hyperpolarization-activated current (Ih) in ventral tegmental area dopamine
neurons: involvement of 5-HT2 receptors and protein kinase C. J. Neurophysiol.
90, 3201e3212.
Lu, Y., Dong, H., Gao, Y., Gong, Y., Ren, Y., Gu, N., Zhou, S., Xia, N., Sun, Y.Y., Ji, R.R.,
Xiong, L., 2013. A feed-forward spinal cord glycinergic neural circuit gates
mechanical allodynia. J. Clin. Investig. 123, 4050e4062.
Lupica, C.R., Bell, J.A., Hoffman, A.F., Watson, P.L., 2001. Contribution of the
hyperpolarization-activated current (Ih) to membrane potential and GABA
release in hippocampal interneurons. J. Neurophysiol. 86, 261e268.
Makuch, W., Mika, J., Rojewska, E., Zychowska, M., Przewlocka, B., 2013. Effects of
selective and non-selective inhibitors of nitric oxide synthase on morphine-
N. Liu et al. / Neuropharmacology 95 (2015) 110e120120and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.
Neuropharmacology 75, 445e457.
Mao-Ying, Q.L., Wang, X.W., Yang, C.J., Li, X., Mi, W.L., Wu, G.C., Wang, Y.Q., 2012.
Robust spinal neuroinﬂammation mediates mechanical allodynia in Walker 256
induced bone cancer rats. Mol. Brain 5, 16.
Martinez, V., Szekely, B., Lemarie, J., Martin, F., Gentili, M., Ben Ammar, S.,
Lepeintre, J.F., Garreau de Loubresse, C., Chauvin, M., Bouhassira, D., Fletcher, D.,
2013. The efﬁcacy of a glial inhibitor, minocycline, for preventing persistent
pain after lumbar discectomy: a randomized, double-blind, controlled study.
Pain 154, 1197e1203.
McCormick, D.A., Pape, H.C., 1990. Properties of a hyperpolarization-activated
cation current and its role in rhythmic oscillation in thalamic relay neurones.
J. Physiol. 431, 291e318.
Mei, X.P., Sakuma, Y., Xie, C., Wu, D., Ho, I., Kotani, J., Xu, L.X., 2013. Depressing
interleukin-1 b contributed to the synergistic effects of tramadol and minocy-
cline on spinal nerve ligation-induced neuropathic pain. Neurosignals 22,
30e42.
Melnick, I., 2008. Morphophysiologic properties of islet cells in substantia gelati-
nosa of the rat spinal cord. Neurosci. Lett. 446, 65e69.
Mika, J., Wawrzczak-Bargiela, A., Osikowicz, M., Makuch, W., Przewlocka, B., 2009.
Attenuation of morphine tolerance by minocycline and pentoxifylline in naive
and neuropathic mice. Brain Behav. Immun. 23, 75e84.
Momin, A., Cadiou, H., Mason, A., McNaughton, P.A., 2008. Role of the
hyperpolarization-activated current Ih in somatosensory neurons. J. Physiol.
586, 5911e5929.
Nolan, M.F., Malleret, G., Dudman, J.T., Buhl, D.L., Santoro, B., Gibbs, E.,
Vronskaya, S., Buzsaki, G., Siegelbaum, S.A., Kandel, E.R., Morozov, A., 2004.
A behavioral role for dendritic integration: HCN1 channels constrain spatial
memory and plasticity at inputs to distal dendrites of CA1 pyramidal neu-
rons. Cell 119, 719e732.
Owolabi, S.A., Saab, C.Y., 2006. Fractalkine and minocycline alter neuronal activity in
the spinal cord dorsal horn. FEBS Lett. 580, 4306e4310.
Pabreja, K., Dua, K., Sharma, S., Padi, S.S., Kulkarni, S.K., 2011. Minocycline attenuates
the development of diabetic neuropathic pain: possible anti-inﬂammatory and
anti-oxidant mechanisms. Eur. J. Pharmacol. 661, 15e21.
Pape, H.C., McCormick, D.A., 1989. Noradrenaline and serotonin selectively modu-
late thalamic burst ﬁring by enhancing a hyperpolarization-activated cation
current. Nature 340, 715e718.
Papp, I., Hollo, K., Antal, M., 2010. Plasticity of hyperpolarization-activated and
cyclic nucleotid-gated cation channel subunit 2 expression in the spinal dorsal
horn in inﬂammatory pain. Eur. J. Neurosci. 32, 1193e1201.
Papp, I., Szucs, P., Hollo, K., Erdelyi, F., Szabo, G., Antal, M., 2006. Hyperpolarization-
activated and cyclic nucleotide-gated cation channel subunit 2 ion channels
modulate synaptic transmission from nociceptive primary afferents containing
substance P to secondary sensory neurons in laminae I-IIo of the rodent spinal
dorsal horn. Eur. J. Neurosci. 24, 1341e1352.
Peng, B.W., Justice, J.A., Zhang, K., He, X.H., Sanchez, R.M., 2010. Increased basal
synaptic inhibition of hippocampal area CA1 pyramidal neurons by an antiep-
ileptic drug that enhances IH. Neuropsychopharmacology 35, 464e472.
Pevida, M., Lastra, A., Hidalgo, A., Baamonde, A., Menendez, L., 2013. Spinal CCL2
and microglial activation are involved in paclitaxel-evoked cold hyperalgesia.
Brain Res. Bull. 95, 21e27.
Pu, S., Xu, Y., Du, D., Yang, M., Zhang, X., Wu, J., Jiang, W., 2013. Minocycline at-
tenuates mechanical allodynia and expression of spinal NMDA receptor 1
subunit in rat neuropathic pain model. J. Physiol. Biochem. 69, 349e357.
Raghavendra, V., Tanga, F., DeLeo, J.A., 2003. Inhibition of microglial activation at-
tenuates the development but not existing hypersensitivity in a rat model of
neuropathy. J. Pharmacol. Exp. Ther. 306, 624e630.Rivera-Arconada, I., Roza, C., Lopez-Garcia, J.A., 2013. Characterization of
hyperpolarization-activated currents in deep dorsal horn neurons of neonate
mouse spinal cord in vitro. Neuropharmacology 70, 148e155.
Rodrigues, A.R., Oertel, D., 2006. Hyperpolarization-activated currents regulate
excitability in stellate cells of the mammalian ventral cochlear nucleus.
J. Neurophysiol. 95, 76e87.
Santos, S.F., Rebelo, S., Derkach, V.A., Safronov, B.V., 2007. Excitatory interneurons
dominate sensory processing in the spinal substantia gelatinosa of rat.
J. Physiol. 581, 241e254.
Southan, A.P., Morris, N.P., Stephens, G.J., Robertson, B., 2000. Hyperpolarization-
activated currents in presynaptic terminals of mouse cerebellar basket cells.
J. Physiol. 526 (Pt 1), 91e97.
Syngle, A., Verma, I., Krishan, P., Garg, N., Syngle, V., 2014. Minocycline improves
peripheral and autonomic neuropathy in type 2 diabetes: MIND study. Neurol.
Sci. 35, 1067e1073.
Tadros, M.A., Harris, B.M., Anderson, W.B., Brichta, A.M., Graham, B.A., Callister, R.J.,
2012. Are all spinal segments equal: intrinsic membrane properties of super-
ﬁcial dorsal horn neurons in the developing and mature mouse spinal cord.
J. Physiol. 590, 2409e2425.
Takasu, K., Ono, H., Tanabe, M., 2010. Spinal hyperpolarization-activated cyclic
nucleotide-gated cation channels at primary afferent terminals contribute to
chronic pain. Pain 151, 87e96.
Tanga, F.Y., 2005. The CNS role of Toll-like receptor 4 in innate neuroimmunity and
painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 102, 5856e5861.
Tu, H., Deng, L., Sun, Q., Yao, L., Han, J.S., Wan, Y., 2004. Hyperpolarization-activated,
cyclic nucleotide-gated cation channels: roles in the differential electrophysi-
ological properties of rat primary afferent neurons. J. Neurosci. Res. 76,
713e722.
Van Hook, M.J., Berson, D.M., 2010. Hyperpolarization-activated current (Ih) in
ganglion-cell photoreceptors. PLoS One 5, e15344.
van Welie, I., van Hooft, J.A., Wadman, W.J., 2004. Homeostatic scaling of neuronal
excitability by synaptic modulation of somatic hyperpolarization-activated Ih
channels. Proc. Natl. Acad. Sci. U. S. A. 101, 5123e5128.
Wall, P.D., 1980. The role of substantia gelatinosa as a gate control. Res. Publ. Assoc.
Res. Nerv. Ment. Dis. 58, 205e231.
Weng, X., Smith, T., Sathish, J., Djouhri, L., 2012. Chronic inﬂammatory pain is
associated with increased excitability and hyperpolarization-activated current
(Ih) in C- but not Ad-nociceptors. Pain 153, 900e914.
Yao, H., Donnelly, D.F., Ma, C., LaMotte, R.H., 2003. Upregulation of the
hyperpolarization-activated cation current after chronic compression of the
dorsal root ganglion. J. Neurosci. 23, 2069e2074.
Yasaka, T., Tiong, S.Y., Hughes, D.I., Riddell, J.S., Todd, A.J., 2010. Populations of
inhibitory and excitatory interneurons in lamina II of the adult rat spinal dorsal
horn revealed by a combined electrophysiological and anatomical approach.
Pain 151, 475e488.
Zanjani, T.M., Sabetkasaei, M., Mosaffa, N., Manaheji, H., Labibi, F., Farokhi, B., 2006.
Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain.
Eur. J. Pharmacol. 538, 66e72.
Zheng, J., Lu, Y., Perl, E.R., 2010. Inhibitory neurones of the spinal substantia
gelatinosa mediate interaction of signals from primary afferents. J. Physiol. 588,
2065e2075.
Zhuang, Z.Y., Gerner, P., Woolf, C.J., Ji, R.R., 2005. ERK is sequentially activated in
neurons, microglia, and astrocytes by spinal nerve ligation and contributes to
mechanical allodynia in this neuropathic pain model. Pain 114, 149e159.
Zychowska, M., Rojewska, E., Kreiner, G., Nalepa, I., Przewlocka, B., Mika, J., 2013.
Minocycline inﬂuences the anti-inﬂammatory interleukins and enhances the
effectiveness of morphine under mice diabetic neuropathy. J. Neuroimmunol.
262, 35e45.
